Park Avenue Institutional Advisers LLC

In its 13F for Q4 2025 (holdings as of December 31, 2025, filed February 10, 2026), Park Avenue Institutional Advisers LLC reported 3 stock positions worth $1.0 million. Its top holding was Revolution Medicines (RVMD) at 40.5% of the portfolio, followed by Braze Class A (BRZE, 30.3%) and Servicetitan Class A (TTAN, 29.2%). Compared with Q3 2025, it opened 3 new positions and sold out of 1. The biggest buy was a new position in Revolution Medicines (RVMD) and the biggest sale an exit from Janus Hdrsn Ass BKD Sec ETF (JABS).

Most Recent 13F
Q2 2026
Location
New York, NY
CIK
0001640801
Portfolio Value
$1.0M (Q4 2025)
SEC Filing
0001193125-26-044450 ↗ filed Feb 10, 2026

Holdings Value

0$50.0M$100.0M$150.0M$200.0M Q1 2024: $45.3M Q1 2024 Q2 2024: $67.2M Q2 2024 Q3 2024: $53.6M Q3 2024 Q4 2024: $14.0M Q4 2024 Q3 2025: $99.6M Q3 2025 Q4 2025: $1.0M $1.0M Q4 2025 Q1 2026: $199.2M Q1 2026 Q2 2026: $198.7M Q2 2026

Holdings 3 stocks · $1.0M
RVMD Revolution Medicines Inc. 40.50% 5,115 $407K New
BRZE Braze Inc. Class A 30.31% 8,890 $305K New
TTAN Servicetitan Inc. Class A 29.19% 2,757 $294K New

Portfolio Sells Q3 2025 → Q4 2025
JABS Janus Hdrsn Ass BKD Sec ETF Sold out 0.00% −100.00

Portfolio Buys Q3 2025 → Q4 2025
RVMD Revolution Medicines Inc. New 40.50% +40.50
BRZE Braze Inc. Class A New 30.31% +30.31
TTAN Servicetitan Inc. Class A New 29.19% +29.19

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 2$198.7MJA, JABS
Q1 2026 5$199.2MJA, JABS, RVMD, BRZE, TTAN
Q4 2025 3$1.0MRVMD, BRZE, TTAN
Q3 2025 1$99.6MJABS
Q4 2024 3$14.0MMBB, BKLN, SRLN
Q3 2024 5$53.6MMBB, VMBS, JNK, HYG, SRLN
Q2 2024 5$67.2MMBB, VMBS, BKLN, SRLN, JNK
Q1 2024 5$45.3MMBB, VMBS, BKLN, SRLN, COIN